Heme Oxygenase-1 as a Target for the Design of Gene and Pharmaceutical Therapies for Autoimmune Diseases

E-ISSN： 1875-5631|14|3|218-235

ISSN： 1566-5232

Source： Current Gene Therapy, Vol.14, Iss.3, 2014-06, pp. : 218-235

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Heme Oxygenase-1 as a Therapeutic Target in Neurodegenerative Diseases and Brain Infections

Current Pharmaceutical Design, Vol. 14, Iss. 5, 2008-02 ,pp. : 429-442

Bentham Science Publishers

Access to resources Recommend Favorite

Heme Oxygenase: A Target Gene for Anti-Diabetic and Obesity

Current Pharmaceutical Design, Vol. 14, Iss. 5, 2008-01 ,pp. : 412-421

Bentham Science Publishers

Access to resources Recommend Favorite

Involvement of Heme Oxygenase-1 in Neuropsychiatric and Neurodegenerative Diseases

Current Pharmaceutical Design, Vol. 24, Iss. 20, 2018-06 ,pp. : 2283-2302

Bentham Science Publishers

Access to resources Recommend Favorite

Heme Oxygenase-1: A Novel Therapeutic Target in Oxidative Tissue Injuries

Current Medicinal Chemistry, Vol. 11, Iss. 12, 2004-06 ,pp. : 1545-1561

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Statins in the Activation of Heme Oxygenase-1 in Cardiovascular Diseases

Current Drug Targets, Vol. 18, Iss. 6, 2017-03 ,pp. : 674-686

Bentham Science Publishers

Access to resources Recommend Favorite